Clinical Trial Update: A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating AAV2-hAQP1 gene therapy for radiation-induced xerostomia following radiotherapy for upper aerodigestive tract cancers; current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Xerostomia

Drugs mentioned

• AAV2-hAQP1 gene therapy (AAV2-hAQP1)

Snippet

Sponsor: MeiraGTx, LLC | Conditions: Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands | Phase 2 | Status: RECRUITING